Soichiro Ando
Impact in
-
- Lung Cancer Diagnosis and Treatment
- Lung Cancer Treatments and Mutations
Papers in
-
- Cancer-related gene regulation 2
-
- Lung Cancer Diagnosis and Treatment 3
- Co-authors
- Tomohiko Iida (9 shared papers)Hideki Kimura (6 shared papers)Thomas J. Santoro (2 shared papers)Rodney C. Baker (1 shared paper)Takahiro Nakajima (6 shared papers)Makoto Suzuki (4 shared papers)Makoto Suzuki (3 shared papers)Naomichi Iwai (4 shared papers)
- Journals
- Oncology Reports (4 papers)Lung Cancer (2 papers)Respirology (1 paper)BMC Cancer (1 paper)Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (1 paper)
- Partner nations
- JapanUnited StatesChina
In The Last Decade
Soichiro Ando
26 papers receiving 398 citations
Peers
Comparison fields: 5 of 84
- Cancer Research 41
- Pulmonary and Respiratory Medicine 81
- Microbiology 2
- Oncology 62
- Neurology 28
Countries citing papers authored by Soichiro Ando
This map shows the geographic impact of Soichiro Ando's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Soichiro Ando with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Soichiro Ando more than expected).
Fields of papers citing papers by Soichiro Ando
This network shows the impact of papers produced by Soichiro Ando. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Soichiro Ando. The network helps show where Soichiro Ando may publish in the future.
Co-authors
The 25 scholars most cited alongside Soichiro Ando, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 62 | |
| 2 | 2005 | 44 | |
| 3 | 2006 | 40 | |
| 4 | The prognostic value of both neuron-specific enolase (NSE) and Cyfra21-1 in small cell lung cancer. | 2004 | 39 |
| 5 | 2006 | 31 | |
| 6 | 1998 | 30 | |
| 7 | Positive reactions for both Cyfra21-1 and CA125 indicate worst prognosis in non-small cell lung cancer. | 2003 | 28 |
| 8 | 2003 | 22 | |
| 9 | 2005 | 22 | |
| 10 | 2006 | 16 | |
| 11 | 2003 | 13 | |
| 12 | 2018 | 10 | |
| 13 | 2007 | 9 | |
| 14 | 2000 | 8 | |
| 15 | 2019 | 7 | |
| 16 | VEGF in patients with non-small cell lung cancer during combination chemotherapy of carboplatin and paclitaxel. | 2009 | 6 |
| 17 | 2005 | 6 | |
| 18 | 2005 | 4 | |
| 19 | 1998 | 3 | |
| 20 | 1993 | 3 |
About Soichiro Ando
Soichiro Ando is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Epidemiology, Rheumatology and Neurology, having authored 26 papers that have together received 410 indexed citations. Recurring topics across this work include Influenza Virus Research Studies (3 papers), Myasthenia Gravis and Thymoma (3 papers), Lung Cancer Diagnosis and Treatment (3 papers), Cancer-related gene regulation (2 papers), Otitis Media and Relapsing Polychondritis (2 papers), Lung Cancer Research Studies (2 papers), Autoimmune and Inflammatory Disorders (2 papers) and Respiratory viral infections research (2 papers). The work is most often cited by research in Cancer Research (41 citations), Pulmonary and Respiratory Medicine (81 citations), Microbiology (2 citations), Oncology (62 citations) and Neurology (28 citations). Soichiro Ando has collaborated with scholars based in Japan, United States and China. Frequent co-authors include Tomohiko Iida, Hideki Kimura, Thomas J. Santoro, Rodney C. Baker, Takahiro Nakajima, Hideki Kimura, Makoto Suzuki, Makoto Suzuki, Naomichi Iwai and Naoyoshi Yamamoto. Their work appears in journals such as Oncology Reports, Lung Cancer, Respirology, BMC Cancer and Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.